Intravitreal anti-vascular endothelial growth factor combined with half-fluence photodynamic therapy for choroidal neovascularization in chronic central serous chorioretinopathy-Reference-Cited by-同舟云学术

Intravitreal anti-vascular endothelial growth factor combined with half-fluence photodynamic therapy for choroidal neovascularization in chronic central serous chorioretinopathy

Published:2016-03-11 Issue:6 Volume:30 Page:805-811
ISSN:0950-222X
Container-title:Eye
language:en
Short-container-title:Eye

Author:

Smretschnig E,Hagen S,Glittenberg C,Ristl R,Krebs I,Binder S,Ansari-Shahrezaei S

Publisher

Springer Science and Business Media LLC

Subject

Ophthalmology

Link

http://www.nature.com/articles/eye201641.pdf

Reference36 articles.

1. Fine HF, Ober MD, Hariprasad SM . Current concepts in managing central serous chorioretinopathy. Ophthalmic Surg Lasers Imaging Retina 2014; 45: 9–13.

2. Gass JD . Pathogenesis of disciform detachment of the neuroepithelium. Am J Ophthalmol 1967; 63: 1–139.

3. Inhoffen W, Ziemssen F, Bartz-Schmidt KU . Chronic central serous chorioretinopathy (cCSC): differential diagnosis to choroidal neovascularisation (CNV) secondary to age-related macular degeneration (AMD). Klin Monbl Augenheilkd 2012; 229: 889–896.

4. Boyer DS, Antoszyk AN, Awh CC, Bhisitkul RB, Shapiro H, Acharya NR, MARINA Study Group. Subgroup analysis of the MARINA study of ranibizumab in neovascular age-related macular degeneration. Ophthalmology 2007; 114: 246–252.

5. Ferrara N, Damico L, Shams N, Lowman H, Kim R . Development of ranibizumab, an anti-vascular endothelial growth factor antigen binding fragment, as therapy for neovascular age-related macular degeneration. Review Retina 2006; 26: 859–870.

Cited by 30 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Current and emerging treatment options for central serous chorioretinopathy;Expert Review of Ophthalmology;2024-04-10

2. Clinical Landscape of Central Serous Chorioretinopathy in Germany: Retina.net CSC Registry Report Number 1;Ophthalmologica;2024

3. Intravitreal injections with anti-VEGF agent aflibercept versus subthreshold micropulse laser for chronic central serous chorioretinopathy: the alternative treatment regimens for verteporfin-shortage in China;Annals of Medicine;2023-06-29

4. ENLARGEMENT OF CHOROIDAL NEOVASCULARIZATION BEFORE RECURRENCE AFTER PHOTODYNAMIC THERAPY FOR PACHYCHOROID NEOVASCULOPATHY;Retina;2023-05-22

5. Two-year outcome of half-time photodynamic therapy for chronic central serous chorioretinopathy with and without choroidal neovascularization;PLOS ONE;2023-05-02